Beta-Glucan Modulates Monocyte Plasticity and Differentiation Capacity to Mitigate DSS-Induced Colitis

Read full text Summarise with VIRAT
Authors: Yinyin Lv, Yanyun Fan, Qingxiang Gao, Qiongyun Chen, Yiqun Hu, Lin Wang, Huaxiu Shi, Ermei Chen, Qinyu Xu, Ying Cai, Qingqi Fan, Linying Li
+4 more Dan Du, Jianlin Ren, Shih‐Chin Cheng, Hongzhi Xu
Cited by: 0
References: 63

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Trained immunity involves the reprogramming of innate immune cells after an initial exposure, resulting in heightened inflammatory responses to subsequent stimuli and enhanced bactericidal capacity during infection. However, this proinflammatory state could also exacerbate chronic conditions like inflammatory bowel disease (IBD), which is characterized by persistent inflammation and microbial imbalance. It remains unclear how trained immunity influences IBD pathogenesis and whether it can be harnessed therapeutically. In our study, pretreatment with β-glucan reprogrammed bone marrow hematopoietic progenitors and peripheral monocytes, inducing a profound shift in monocyte plasticity and significantly reducing the severity of dextran sulfate sodium (DSS)–induced colitis. Adoptive transfer of bone marrow or peripheral monocytes from β-glucan–trained mice into naive mice conferred robust protection against colitis, demonstrating that this protective effect is transferable. Trained mice also displayed improved clearance of intestinal bacterial infections. Single-cell RNA sequencing revealed an expansion of reparative Cx3cr1⁺ macrophages derived from Ly6Chi monocytes, correlating with accelerated colonic epithelial regeneration. Collectively, these findings reveal how β-glucan–induced trained immunity modulates monocyte differentiation to ameliorate experimental colitis, highlighting the potential of harnessing trained immunity as a therapeutic strategy to recalibrate innate immune responses and restore gut homeostasis in IBD, shedding light for future clinical applications.

Fields of Study & Subjects

Immune responses and vaccinations Inflammatory Bowel Disease Immune cells in cancer

Publication details

Journal / source
eLife
Publication date
25 March 2026
Language
EN
Document type
Preprint